- Home
- AQST vs KULR Comparison
AQST vs KULR Comparison
Compare AQST & KULR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- KULR
- Stock Information
- Founded
- AQST 2004
- KULR 2013
- Country
- AQST United States
- KULR United States
- Employees
- AQST N/A
- KULR N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- KULR Electrical Products
- Sector
- AQST Health Care
- KULR Technology
- Exchange
- AQST Nasdaq
- KULR Nasdaq
- Market Cap
- AQST 274.4M
- KULR 275.2M
- IPO Year
- AQST 2018
- KULR N/A
- Fundamental
- Price
- AQST $3.02
- KULR $1.46
- Analyst Decision
- AQST Strong Buy
- KULR Strong Buy
- Analyst Count
- AQST 7
- KULR 2
- Target Price
- AQST $10.57
- KULR $5.00
- AVG Volume (30 Days)
- AQST 1.3M
- KULR 13.5M
- Earning Date
- AQST 03-05-2025
- KULR 03-27-2025
- Dividend Yield
- AQST N/A
- KULR N/A
- EPS Growth
- AQST N/A
- KULR N/A
- EPS
- AQST N/A
- KULR N/A
- Revenue
- AQST $57,561,000.00
- KULR $9,700,738.00
- Revenue This Year
- AQST N/A
- KULR $6.31
- Revenue Next Year
- AQST $35.72
- KULR $76.78
- P/E Ratio
- AQST N/A
- KULR N/A
- Revenue Growth
- AQST 13.79
- KULR 4.20
- 52 Week Low
- AQST $2.24
- KULR $0.20
- 52 Week High
- AQST $5.80
- KULR $5.49
- Technical
- Relative Strength Index (RSI)
- AQST 50.92
- KULR 45.32
- Support Level
- AQST $3.05
- KULR $1.42
- Resistance Level
- AQST $3.24
- KULR $1.80
- Average True Range (ATR)
- AQST 0.20
- KULR 0.18
- MACD
- AQST 0.04
- KULR 0.04
- Stochastic Oscillator
- AQST 57.47
- KULR 50.63
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About KULR KULR Technology Group Inc.
KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems; artificial intelligence and Cloud computing; energy storage; and 5G communication technologies.